Robin E. Offord

8.4k total citations · 3 hit papers
152 papers, 7.0k citations indexed

About

Robin E. Offord is a scholar working on Molecular Biology, Virology and Immunology. According to data from OpenAlex, Robin E. Offord has authored 152 papers receiving a total of 7.0k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Molecular Biology, 30 papers in Virology and 28 papers in Immunology. Recurrent topics in Robin E. Offord's work include HIV Research and Treatment (30 papers), Monoclonal and Polyclonal Antibodies Research (19 papers) and Chemical Synthesis and Analysis (16 papers). Robin E. Offord is often cited by papers focused on HIV Research and Treatment (30 papers), Monoclonal and Polyclonal Antibodies Research (19 papers) and Chemical Synthesis and Analysis (16 papers). Robin E. Offord collaborates with scholars based in Switzerland, United Kingdom and United States. Robin E. Offord's co-authors include Oliver Hartley, Amanda E. I. Proudfoot, Keith Rose, Timothy N. C. Wells, Hubert Gaertner, J.D. Priddle, Michael M. Lederman, Donald E. Mosier, Laurent Picard and Raphaële Buser and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Robin E. Offord

151 papers receiving 6.5k citations

Hit Papers

Electrophoretic Mobilitie... 1966 2026 1986 2006 1966 1975 1997 250 500 750

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Robin E. Offord 3.1k 1.8k 1.6k 1.1k 844 152 7.0k
Martin S. Springer 2.0k 0.7× 872 0.5× 1.8k 1.1× 844 0.7× 530 0.6× 65 4.9k
Markus G. Grütter 7.8k 2.5× 605 0.3× 2.2k 1.4× 1.6k 1.4× 621 0.7× 168 11.3k
E.A. Stura 5.2k 1.7× 607 0.3× 2.5k 1.5× 1.3k 1.1× 833 1.0× 172 10.4k
Irwin Chaiken 3.9k 1.3× 1.3k 0.7× 869 0.5× 351 0.3× 987 1.2× 221 6.6k
Carl R. Alving 4.4k 1.4× 1.2k 0.7× 4.4k 2.7× 343 0.3× 1.3k 1.5× 261 10.7k
Martin Rosenberg 11.0k 3.6× 878 0.5× 1.3k 0.8× 1.5k 1.3× 1.3k 1.6× 181 15.2k
F.F. Vajdos 4.0k 1.3× 935 0.5× 634 0.4× 1.1k 1.0× 578 0.7× 20 6.1k
Mark R. Wormald 8.6k 2.8× 1.1k 0.6× 3.6k 2.2× 477 0.4× 531 0.6× 173 12.8k
Rebecca L. Rich 5.1k 1.6× 615 0.4× 873 0.5× 843 0.7× 575 0.7× 71 7.8k
Paul M. Keller 2.0k 0.6× 766 0.4× 1.2k 0.7× 598 0.5× 774 0.9× 81 6.4k

Countries citing papers authored by Robin E. Offord

Since Specialization
Citations

This map shows the geographic impact of Robin E. Offord's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robin E. Offord with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robin E. Offord more than expected).

Fields of papers citing papers by Robin E. Offord

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robin E. Offord. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robin E. Offord. The network helps show where Robin E. Offord may publish in the future.

Co-authorship network of co-authors of Robin E. Offord

This figure shows the co-authorship network connecting the top 25 collaborators of Robin E. Offord. A scholar is included among the top collaborators of Robin E. Offord based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robin E. Offord. Robin E. Offord is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
McBride, J.W., Karl Malcolm, David Cameron, et al.. (2019). Development and pharmacokinetics of a combination vaginal ring for sustained release of dapivirine and the protein microbicide 5P12-RANTES. International Journal of Pharmaceutics. 564. 207–213. 9 indexed citations
2.
Cerini, Fabrice, Robin E. Offord, Ian McGowan, & Oliver Hartley. (2017). Stability of 5P12-RANTES, A Candidate Rectal Microbicide, in Human Rectal Lavage. AIDS Research and Human Retroviruses. 33(8). 768–777. 11 indexed citations
3.
Cerini, Fabrice, Alan Landay, Michael M. Lederman, et al.. (2008). Chemokine Analogues Show Suitable Stability for Development as Microbicides. JAIDS Journal of Acquired Immune Deficiency Syndromes. 49(5). 472–476. 30 indexed citations
4.
Gaertner, Hubert, Fabrice Cerini, Brett D. Dufour, et al.. (2008). Highly potent HIV inhibition: engineering a key anti-HIV structure from PSC-RANTES into MIP-1 /CCL4. Protein Engineering Design and Selection. 21(2). 65–72. 20 indexed citations
5.
Hartley, Oliver & Robin E. Offord. (2005). Engineering Chemokines to Develop Optimized HIV Inhibitors. Current Protein and Peptide Science. 6(3). 207–219. 30 indexed citations
6.
Chvatchko, Yolande, Amanda E. I. Proudfoot, Raphaële Buser, et al.. (2003). Inhibition of Airway Inflammation by Amino-Terminally Modified RANTES/CC Chemokine Ligand 5 Analogues Is Not Mediated through CCR3. The Journal of Immunology. 171(10). 5498–5506. 43 indexed citations
7.
Stöcklin, Reto, Lan Phuong Vu, Fabrice Cerini, et al.. (2003). Positive and Negative Labeling of Human Proinsulin, Insulin, and C-Peptide with Stable Isotopes: New Tools for In Vivo Pharmacokinetic and Metabolic Studies. Humana Press eBooks. 146. 293–315. 7 indexed citations
8.
Storto, Giovanni, F. Buchegger, Robert Waibel, et al.. (2001). Biokinetics of a F(ab′) 3 Iodine-131 Labeled Antigen Binding Construct (MAb 35) Directed Against CEA in Patients with Colorectal Carcinoma. Cancer Biotherapy and Radiopharmaceuticals. 16(5). 371–379. 6 indexed citations
9.
Rusconi, Stefano, Donatella Arienti, Daria Trabattoni, et al.. (1999). Aminooxypentane-RANTES, an Inhibitor of R5 Human Immunodeficiency Virus Type 1, Increases the Interferon gamma to Interleukin 10 Ratio without Impairing Cellular Proliferation. AIDS Research and Human Retroviruses. 15(10). 861–867. 4 indexed citations
10.
Proudfoot, Amanda E. I., Raphaële Buser, Frédéric Borlat, et al.. (1999). Amino-terminally Modified RANTES Analogues Demonstrate Differential Effects on RANTES Receptors. Journal of Biological Chemistry. 274(45). 32478–32485. 127 indexed citations
11.
Solari, Roberto, Robin E. Offord, Jean‐Pierre Aubry, et al.. (1997). Receptor-mediated Endocytosis of CC-chemokines. Journal of Biological Chemistry. 272(15). 9617–9620. 72 indexed citations
12.
Offord, Robin E., Hubert Gaertner, Timothy N. C. Wells, & Amanda E. I. Proudfoot. (1997). Synthesis and evaluation of fluorescent chemokines labeled at the amino terminal. Methods in enzymology on CD-ROM/Methods in enzymology. 287. 348–369. 15 indexed citations
13.
Kippen, Alistair D., Fabrice Cerini, L. Vadas, et al.. (1997). Development of an Isotope Dilution Assay for Precise Determination of Insulin, C-peptide, and Proinsulin Levels in Non-diabetic and Type II Diabetic Individuals with Comparison to Immunoassay. Journal of Biological Chemistry. 272(19). 12513–12522. 111 indexed citations
14.
Gaertner, Hubert, et al.. (1994). Site-Specific Religation of G-CSF Fragments through a Thioether Bond. Bioconjugate Chemistry. 5(4). 333–338. 6 indexed citations
15.
Fisch, Igor, et al.. (1992). Site-specific modification of a fragment of a chimeric monoclonal antibody using reverse proteolysis. Bioconjugate Chemistry. 3(2). 147–153. 23 indexed citations
16.
Rose, Keith, et al.. (1991). Reaction mechanism of trypsin-catalysed semisynthesis of human insulin studied by fast atom bombardment mass spectrometry. Protein Engineering Design and Selection. 4(4). 409–412. 5 indexed citations
17.
Rose, Keith, et al.. (1991). Preparation of well-defined protein conjugates using enzyme-assisted reverse proteolysis. Bioconjugate Chemistry. 2(3). 154–159. 24 indexed citations
18.
Humphries, John Eric, Robin E. Offord, & Richard A. Smith. (1991). Chemical methods of protein synthesis and modification. Current Opinion in Biotechnology. 2(4). 539–543. 6 indexed citations
19.
Offord, Robin E., Julien Philippe, John Davis, Philippe A. Halban, & Michael Berger. (1979). Inhibition of degradation of insulin by ophthalamic acid and by a bovine pancreatic proteinase inhibitor. Biochemical Journal. 182(1). 249–251. 17 indexed citations
20.
Dissanayake, A. S., et al.. (1974). Identifying toxic fractions of wheat gluten and their effect on the jejunal mucosa in coeliac disease. Gut. 15(12). 931–946. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026